BMC Cancer · 2019 · 47 citations · 19 references
MedicineOncologyPathologyNeoplasiaSurvival AnalysisTumor ProgressionCancer BiomarkersCancer Survival AnalysisMalignant NeoplasmsPancreatic CancerPrognostic AssessmentSurvival ModelingCancer Prognostic ModelingLeukocyte CountsOverall MortalityPrognostic Biomarker ModelingPrognostic Factors AnalysisPrognostic IndicesPrognostic ModelsTotal Serum Bilirubin
BACKGROUND: The prognostic role of serum alkaline phosphatase (ALP) has been found in several kinds of solid malignant tumor, but has never been extensively discussed in pancreatic cancer, especially through the application of dynamic survival model which incorporates the varying nature of ALP measurements. METHODS: We conducted a retrospective study which successfully collected 551 histopathologically confirmed pancreatic ductal adenocarcinoma (PDAC) patients from a cancer specialized hospital in southwest China. The association between variant ALP which measured during the whole survival period and the overall survival (OS) of PDAC patients was evaluated by using dynamic Anderson-Gill (AG) model. Exhaustive sensitivity analysis was performed by adopting continuous cut-offs of ALP. RESULTS: ) quartiles were observed 1.14 (95% CI: 0.29-4.56), 3.93 (95% CI: 1.23-12.60), 3.87 (95% CI: 1.32-11.36) folds of death hazard; whereas in un-resected PDAC patients, the hazard ratios (HRs) were 1.15 (95% CI: 0.79-1.68), 1.92 (95% CI: 1.32-2.78), and 1.97 (95% CI: 1.30-2.98), respectively. Sensitivity analysis revealed that, for both resected and un-resected patients, the results of AG model were robust with regard to various cut-offs of ALP, and an increased ALP was in general associated with significantly increased hazard of death. CONCLUSION: Serum ALP during the survival period was significantly associated with the OS of PDAC patients, especially for resected early stage PDAC patients. Future studies with expanded sample size and refined prospective design should be implemented to corroborate our major findings. Besides, the underlying mechanism for this possible hazardous role of ALP should also be investigated.
19
Manuela Quaresma, Michel P. Coleman, Bernard Rachet · The Lancet · 2014 · 465 citations · Full text
Medicine, Biostatistics, Oncology +14
Incidence and Survival of Pancreatic Head and Body and Tail Cancers
Melvin Lau, Jessica A. Davila, Yasser H. Shaib · Pancreas · 2010 · 174 citations
Aude Fléchon, Damien Pouessel, Céline Ferlay et al. · Annals of Oncology · 2011 · 143 citations · Full text
Medicine, Oncology, Pharmacology +17